Angiodysplasia refers to fragile, abnormally dilated blood vessels that develop in the wall of the gastrointestinal tract and are one of the most common causes of intestinal bleeding in older adults.1JAMA Internal Medicine. Angiodysplasia and Lower Gastrointestinal Tract Bleeding in Elderly Patients These lesions are typically small, flat, and reddish, sitting in the inner lining of the gut where they can ooze blood intermittently for months or years. The clinical picture ranges from slow, barely noticeable blood loss that quietly drains iron stores to sudden, serious hemorrhage requiring emergency care.2International Journal of Surgery Case Reports. Angiodysplasia in terminal ileum: Case report and review of literature What makes angiodysplasia particularly frustrating for patients and physicians alike is that the lesions are easy to miss, tend to recur, and sit at the intersection of several other medical conditions that complicate management.
How These Abnormal Vessels Form
The leading explanation for angiodysplasia centers on what happens to the tiny veins in the gut wall over decades of use. The colon constantly contracts and relaxes, and each contraction briefly squeezes the small veins that run through the muscular layer. Over years, this repeated, low-grade obstruction is thought to cause the veins to gradually dilate and weaken.3PubMed. Review article: gastrointestinal angiodysplasia – pathogenesis, diagnosis and management The capillaries feeding into those veins eventually lose their normal structure too, creating the thin-walled, dilated tangles that endoscopists see during a colonoscopy.
A key driver of this process involves a growth signal called vascular endothelial growth factor, or VEGF. Research has shown that VEGF is strongly expressed in the tissue of angiodysplasia lesions. In one study, strong VEGF activity was found in about three-quarters of patients with angiodysplasia, while normal colon tissue showed very little.4PubMed. Role of vascular endothelial growth factor in angiodysplasia: an interventional study with thalidomide Another investigation detected VEGF in nearly 90% of angiodysplasia specimens, compared to very limited activity in healthy colon.5PubMed. Increased expression of angiogenic factors in human colonic angiodysplasia Low oxygen in the tissue appears to kick off this VEGF production, which then drives the formation of fragile new blood vessels. This is the same biological pathway exploited by tumors to grow their own blood supply, and understanding it has opened the door to drug treatments that target VEGF directly.
Who Gets Angiodysplasia and Where It Appears
Angiodysplasia is overwhelmingly a condition of aging. The degenerative process in the gut wall takes decades to produce visible lesions, so most patients are diagnosed after age 60. In one Taiwanese study of colonoscopy patients, the prevalence of colonic angiodysplasia was about 0.6%, and nearly 60% of those patients were over 65.6PubMed. Clinical characteristics and risk factors of active bleeding in colonic angiodysplasia among the Taiwanese Traditionally, textbooks describe angiodysplasia as predominantly affecting the cecum and the right side of the colon, and that remains the classic teaching.7JAMA Internal Medicine. Angiodysplasia and Lower Gastrointestinal Tract Bleeding in Elderly Patients The reason usually given is that the cecum has the thinnest muscular wall and the widest diameter, making its veins especially vulnerable to the stretching and compression that drives the disease.
That said, the location picture is less tidy than textbooks suggest. In the same Taiwanese cohort, the left side of the colon was actually the most common site, accounting for about 42% of lesions.8PubMed. Clinical characteristics and risk factors of active bleeding in colonic angiodysplasia among the Taiwanese And angiodysplasia is not confined to the colon at all. The small bowel, particularly the jejunum and ileum, is a well-recognized site, and small-bowel lesions tend to be the hardest to find and the most likely to cause recurrent, mysterious bleeding. In one surgical series, the small bowel accounted for 25 to 40% of bleeding sources.9PubMed Central. Tailored treatment of intestinal angiodysplasia in elderly The stomach, duodenum, and even the esophagus can harbor angiodysplasia as well, though these locations are less common.
The Heyde Syndrome Connection
One of the more fascinating aspects of angiodysplasia is its relationship with aortic stenosis, a condition where the heart’s aortic valve narrows and stiffens. The combination of aortic stenosis, angiodysplasia bleeding, and a specific blood-clotting defect is known as Heyde syndrome, and it demonstrates how seemingly unrelated organs can conspire to create a clinical problem that no single specialty would predict.
Here is how it works. When the aortic valve is severely narrowed, blood is forced through the tight opening at high speed, creating enormous shear stress. That mechanical force chews up large molecules of von Willebrand factor, a protein the body needs to form blood clots effectively.10PubMed Central. Aortic stenosis and Heyde’s syndrome: A comprehensive review Specifically, the largest and most effective forms of von Willebrand factor get destroyed, leaving patients with a subtle bleeding tendency they would never notice under normal circumstances.11PubMed. Acquired von Willebrand syndrome in aortic stenosis But combine that clotting deficiency with the already fragile vessels of angiodysplasia, and what would have been minor oozing becomes persistent, transfusion-dependent bleeding.12PubMed. Heyde Syndrome-Pathophysiology and Perioperative Implications
The remarkable thing about Heyde syndrome is that fixing the valve often fixes the bleeding. In a study of 70 patients who underwent transcatheter aortic valve implantation, about 62% stopped bleeding in the first year, and by one to five years after the procedure, roughly 83% were free of gastrointestinal bleeding.13PubMed Central. Reduction of Gastrointestinal Bleeding in Patients With Heyde Syndrome Undergoing Transcatheter Aortic Valve Implantation In many cases, the gut lesions themselves resolve once normal valve function is restored.14PubMed Central. New onset Heyde’s syndrome presenting after total aortic valve replacement This is a powerful reminder that the source of the bleeding problem can sometimes be in the chest rather than the gut.
Kidney Disease and a Higher Bleeding Risk
Chronic kidney disease is another major risk factor that clinicians watch for, and the connection is clinically significant. Among people with normal kidneys, angiodysplasia accounts for roughly 5% of gastrointestinal bleeding cases. In patients with chronic kidney failure, that figure jumps to somewhere between 19% and 32%.15PubMed Central. Angiodysplasia in Renal Disease Patients: Analysis of Risk Factors and Approach to Manage Such Patients Patients on hemodialysis appear especially vulnerable: one large population study found that dialysis patients had about a tenfold higher incidence of angiodysplasia bleeding compared to kidney patients not on dialysis or to healthy controls.16PubMed Central. Hemodialysis Increases the Risk of Lower Gastrointestinal Bleeding and Angiodysplasia Bleeding: A Nationwide Population Study
Several factors likely contribute. Kidney failure alters platelet function and creates a subtle bleeding tendency somewhat similar to what happens in Heyde syndrome. Dialysis itself involves anticoagulation to keep the machine’s tubing from clotting, which adds another layer of risk. And the chronic low-grade inflammation and metabolic disruption of advanced kidney disease may promote the abnormal vessel growth that defines angiodysplasia in the first place. The practical takeaway is that unexplained anemia in a dialysis patient should prompt consideration of angiodysplasia as a possible cause.
Anticoagulants and the Diagnostic Dilemma
A particularly thorny clinical scenario arises when a patient with angiodysplasia also needs blood thinners. Many of the same older adults who develop these fragile gut vessels also have atrial fibrillation, mechanical heart valves, or a history of blood clots that makes anticoagulation medically necessary. The problem is obvious: blood thinners make angiodysplasia bleed more, but stopping them puts the patient at risk of stroke or other clotting events.
Some cases of angiodysplasia bleeding are in fact unmasked by anticoagulation, appearing from mucosa that looks almost normal on endoscopy, without a visible ulcer or clear vascular abnormality.17PubMed. Non pulsatile active bleeding from the gastrointestinal mucosa without ulceration during anticoagulation therapy As the use of anticoagulants continues to rise in aging populations, this pattern is expected to become more common. There is no clean answer here. Management usually involves a careful weighing of bleeding risk against clotting risk, often on a patient-by-patient basis, with gastroenterologists and cardiologists collaborating. In extreme cases where standard approaches fail and anticoagulation cannot be stopped, novel agents like bevacizumab, a drug that targets the VEGF pathway, have been tried with promising early results.18PubMed. Systemic bevacizumab to facilitate anticoagulation in antiphospholipid syndrome and bleeding gastrointestinal angiodysplasia
Finding the Lesions
Diagnosing angiodysplasia can be surprisingly difficult. The lesions are often only a few millimeters across, flat against the mucosal surface, and their appearance during endoscopy can change depending on the patient’s blood pressure, blood volume, and even the sedation drugs used during the procedure.19PubMed. Ability of naloxone to enhance the colonoscopic appearance of normal colon vasculature and colon vascular ectasias A standard colonoscopy is the first-line tool for the colon, but it misses small-bowel lesions entirely, and the small bowel is where some of the most stubborn bleeding sources hide.
Video capsule endoscopy, in which a patient swallows a pill-sized camera that photographs the entire small intestine as it passes through, has transformed the diagnosis of obscure gastrointestinal bleeding. In one early study, capsule endoscopy identified angiodysplasia as the bleeding source in about 30% of patients with previously unexplained bleeding.20Gastrointestinal Endoscopy. Diagnostic yield and clinical outcomes of capsule endoscopy Later work showed that capsule endoscopy significantly improved the ability to pinpoint the bleeding source even in patients with no prior history of visible angiodysplasia.21PubMed. Gastrointestinal bleeding from angiodysplasia in von Willebrand disease CT angiography can also be useful when bleeding is brisk enough to be detected radiologically, and has been shown to locate the hemorrhage site in a majority of patients with obscure bleeding.22PubMed. Helical CT angiography in gastrointestinal bleeding of obscure origin
It is worth noting that angiodysplasia is not the only type of vascular abnormality in the gut. Dieulafoy lesions involve a single abnormally large artery that erodes through the mucosa and tend to cause sudden, severe bleeds. Arteriovenous malformations are congenital tangles of arteries and veins that are larger and more complex. These distinctions matter because the treatment strategy differs: Dieulafoy lesions respond well to mechanical clips, while arteriovenous malformations often require surgery.23PubMed Central. Diagnosis and therapeutic strategies for small bowel vascular lesions An endoscopic classification system exists to help distinguish these, categorizing vascular lesions into types based on their appearance.24PubMed. Endoscopic classification of vascular lesions of the small intestine (with videos)
Treating Angiodysplasia with Endoscopy
When a lesion is found during endoscopy, the most common immediate treatment is argon plasma coagulation (APC), a technique that uses a jet of ionized argon gas to cauterize the abnormal vessels without making direct contact with the tissue. The results are generally good. In a study of 100 consecutive patients treated with APC, visible bleeding resolved and hemoglobin stabilized without further transfusions in 85% of cases, and the probability of staying free from rebleeding was about 90% at two years.25PubMed. Long-term outcome of argon plasma ablation therapy for bleeding in 100 consecutive patients with colonic angiodysplasia A smaller study reported similar figures, with about 83% of patients having their bleeding controlled at a median follow-up of 18 months and only about a 3% complication rate per procedure.26PubMed. Argon plasma coagulation for prevention of recurrent bleeding from GI angiodysplasias
Mechanical clips (hemoclips) are an alternative, and a multicenter comparison found that patients treated with hemoclips had a rebleeding rate of about 33% compared to roughly 47% with APC over a median of 17 months. However, on deeper statistical analysis, the choice of technique did not independently predict rebleeding, suggesting the difference may reflect patient selection rather than a true advantage of one method over the other.27European Journal of Gastroenterology & Hepatology. Rebleeding after hemoclip versus argon plasma coagulation for gastrointestinal angiodysplasias: a retrospective multicenter study Surgery is reserved for cases where endoscopic treatment repeatedly fails or where lesions are inaccessible, and is rarely needed.
Drug Therapies for Recurrent Bleeding
For patients whose bleeding keeps coming back despite endoscopic treatment, or whose lesions are scattered widely through the small bowel and too numerous to treat one by one, drug therapy becomes central. Two classes of medication have emerged with the strongest evidence.
Somatostatin analogues, such as octreotide and lanreotide, work by reducing blood flow to the gut and suppressing some of the growth factors involved in abnormal vessel formation. A meta-analysis of individual patient data found that treatment with somatostatin analogues cut red blood cell transfusion needs dramatically, from an average of about 13 units before treatment to about 2 units during follow-up, and roughly 83% of patients had a good response.28The Lancet Gastroenterology & Hepatology. Efficacy of somatostatin analogues in patients with gastrointestinal angiodysplasia: a systematic review and individual patient data meta-analysis The OCEAN trial, a randomized controlled study, confirmed that octreotide reduced transfusion requirements significantly compared to standard care.29PubMed. Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study) Long-term data from one center showed that lanreotide reduced both bleeding episodes and transfusion needs over seven years of follow-up.30PubMed. Lanreotide in the management of small bowel angioectasias: seven-year data from a tertiary centre
Thalidomide, a drug with a notorious history but genuine anti-angiogenic properties, has recently gained strong trial evidence. A randomized controlled trial published in the New England Journal of Medicine tested two doses of thalidomide against placebo in patients with recurrent small-bowel angiodysplasia bleeding. Effective response rates were about 69% for the higher dose, 51% for the lower dose, and only 16% for placebo.31PubMed. Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia A systematic review and meta-analysis of randomized trials confirmed that thalidomide improved hemoglobin levels, reduced bleeding, and cut hospitalizations, without severe adverse effects as a group-level finding, though individual patients did experience side effects including constipation, drowsiness, numbness in the hands and feet, and elevated liver enzymes.32PubMed Central. Efficacy and safety of thalidomide in gastrointestinal angiodysplasias: systematic review and meta-analysis with trial sequential analysis of randomized controlled trials Thalidomide’s well-known risk of causing birth defects limits its use to patients who are not pregnant and who are under strict monitoring, but in the typical angiodysplasia patient, who is well past reproductive age, this constraint is less of a practical barrier.
Bevacizumab, a monoclonal antibody that directly blocks VEGF, represents an experimental option for the most refractory cases. Case reports and small series describe patients whose bleeding stopped after bevacizumab infusions, even after all other therapies had failed.33PubMed Central. Bevacizumab for refractory gastrointestinal angiodysplasia: a case report and literature review The rationale is strong given the central role of VEGF in the disease, but the drug is expensive, carries its own risks (including impaired wound healing and blood pressure elevation), and has not been tested in randomized trials for this specific use.
Artificial Intelligence in Capsule Endoscopy
One of the practical bottlenecks of capsule endoscopy is that a single examination produces tens of thousands of images, and a gastroenterologist has to review them all to find lesions that may occupy only a handful of frames. This has made capsule endoscopy a natural testing ground for artificial intelligence. Convolutional neural networks trained on labeled capsule images have shown impressive performance in detecting angiodysplasia. One model achieved about 94% sensitivity and 95% specificity for detecting angiodysplasia and similar vascular lesions.34PubMed Central. Artificial intelligence and capsule endoscopy: automatic detection of vascular lesions using a convolutional neural network More recent deep-learning systems have pushed accuracy even higher, with one reporting close to 100% accuracy for angiodysplasia detection.35PubMed Central. Deep learning-based localization and lesion detection in capsule endoscopy for patients with suspected small-bowel bleeding
Beyond simple detection, some models have been developed to distinguish between different subtypes of angiodysplasia based on their color, branching pattern, and morphology, segmenting them into categories like blue branches, red clusters, and spider-nevus patterns.36PubMed Central. Convolutional neural network-based segmentation network applied to image recognition of angiodysplasias lesion under capsule endoscopy If these tools make it into routine clinical use, they could shorten reading times from an hour or more per study to minutes, reduce the chance of human oversight missing a subtle lesion, and potentially flag lesions that merit treatment versus those that can be monitored.
Living with Angiodysplasia
Because angiodysplasia tends to bleed intermittently rather than catastrophically, it is easy to underestimate the toll it takes on patients. A cross-sectional study of 144 patients found that people with angiodysplasia scored significantly lower on measures of physical quality of life compared to the general population, and more severe disease was independently associated with worse outcomes across multiple domains. Both men and women with angiodysplasia reported substantially more fatigue than their general-population counterparts.37PubMed Central. Decreased health-related quality of life in angiodysplasia patients: A cross-sectional cohort Chronic iron-deficiency anemia, repeated endoscopies, transfusion visits, and the unpredictability of bleeding episodes all contribute to this burden. Many patients describe a frustrating cycle of feeling better after a transfusion, then slowly declining over weeks until the next bleed is detected.
For patients and families navigating the condition, a few practical points are worth keeping in mind. Iron supplementation, sometimes intravenously if oral iron is poorly tolerated or insufficiently absorbed, is a cornerstone of ongoing management. Hemoglobin monitoring should be routine, and a gradual downward trend warrants investigation even if there is no visible bleeding. Patients on anticoagulants or antiplatelet drugs should ensure that their gastroenterologist and prescribing physician communicate regularly, because the risk-benefit calculus may shift over time. And awareness of Heyde syndrome matters: if an older patient with known aortic stenosis develops unexplained anemia, angiodysplasia should be high on the list of possible causes, and addressing the valve disease may be the most effective treatment for the bleeding.